Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01605643 · ClinicalTrials.gov registry record
Biomarker Feedback to Motivate Tobacco Cessation in Pregnant Alaska Native Women
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 150
- Enrollment target
NCT01605643: Completed study, sponsored by Mayo Clinic.
NCT01605643 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01605643 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
Use of tobacco is very high among Alaska Native women. The investigators are conducting a three phase study. The first phase will examine biomarkers of tobacco exposure in pregnant women and their newborns. The second phase is a qualitative study to translate the biomarker findings into intervention messages. The third phase is a pilot of the biomarker feedback intervention compared with a control condition.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2012-03 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01605643
The ClinicalTrials.gov registry entry for NCT01605643 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01605643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01605643 about?
NCT01605643 is a clinical study titled "Biomarker Feedback to Motivate Tobacco Cessation in Pregnant Alaska Native Women". Use of tobacco is very high among Alaska Native women. The investigators are conducting a three phase study. The first phase will examine biomarkers of tobacco exposure in pregnant women and their newborns. The second phase is a qualitative study to translate the biomarker findings into intervention...
What is the current status of trial NCT01605643?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2012-03. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT01605643?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.